Xianghuo He

Active 2007–2025

120
Papers
18,275
Citations
75
h-index
108
i10-index

Citations

Citations per year for Xianghuo He1984: 1 citations1992: 1 citations1997: 1 citations1998: 2 citations2001: 2 citations2003: 2 citations2005: 2 citations2006: 1 citations2007: 2 citations2008: 31 citations2009: 60 citations2010: 79 citations2011: 136 citations2012: 166 citations2013: 152 citations2014: 180 citations2015: 145 citations2016: 198 citations2017: 322 citations2018: 415 citations2019: 1,180 citations2020: 1,336 citations2021: 1,206 citations2022: 896 citations2023: 544 citations2024: 739 citations2025: 289 citations2026: 12 citations1985–1991: no citations, so these years are not shown1993–1996: no citations, so these years are not shown1999–2000: no citations, so these years are not shown2002: no citations, so this year is not shown2004: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 4,369 citing papers, 45.8% of this breakdownUnited States: 1,472 citing papers, 15.4% of this breakdownItaly: 316 citing papers, 3.3% of this breakdownGermany: 279 citing papers, 2.9% of this breakdownUnited Kingdom: 232 citing papers, 2.5% of this breakdownIndia: 197 citing papers, 2.1% of this breakdownIran: 192 citing papers, 2% of this breakdownCanada: 163 citing papers, 1.7% of this breakdownJapan: 153 citing papers, 1.6% of this breakdownFrance: 139 citing papers, 1.5% of this breakdownSouth Korea: 134 citing papers, 1.4% of this breakdownAustralia: 127 citing papers, 1.3% of this breakdown
0%45.8%Other 18.5%

Fields

  • Biochemistry, Genetics and Molecular Biology79.7%
  • Medicine15.4%
  • Immunology and Microbiology1.9%
  • Agricultural and Biological Sciences0.7%
  • Engineering0.6%
  • Neuroscience0.5%
  • Other1.2%

Topics

  • MicroRNA in disease regulation15.3%
  • Circular RNAs in diseases15.2%
  • Cancer-related molecular mechanisms research12.8%
  • RNA modifications and cancer5%
  • Extracellular vesicles in disease3.8%
  • RNA Research and Splicing2.9%
  • Other45%

Coauthors

All papers

Open in search
  1. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis

    Authors: , , , , , , , , , - Cell Research 2015 cited by 2,341

  2. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs

    Authors: , , , , , , , , , , , , , - Nature Communications 2016 cited by 2,199

  3. Extracellular Vesicles Long RNA Sequencing Reveals Abundant mRNA, circRNA, and lncRNA in Human Blood as Potential Biomarkers for Cancer Diagnosis

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Chemistry 2019 cited by 280

  4. exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes

    Authors: , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2017 cited by 584

  5. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer

    Authors: , , , , , , , , , , , , , , , - Cancer Letters 2016 cited by 703

  6. HNRNPL Circularizes ARHGAP35 to Produce an Oncogenic Protein

    Authors: , , , , , , , , , , , , - Advanced Science 2021 cited by 160

  7. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer

    Authors: , , , , , , , , , , , , , , - Breast Cancer Research 2016 cited by 218

  8. Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response

    Authors: , , , , , , , - Molecular Cancer 2020 cited by 197

  9. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , - Gut 2019 cited by 270

  10. Comprehensive characterization of circular RNAs in 1000 human cancer cell lines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Genome Medicine 2019 cited by 172

  11. CRISPR/Cas9 Screens Reveal that Hexokinase 2 Enhances Cancer Stemness and Tumorigenicity by Activating the ACSL4‐Fatty Acid β‐Oxidation Pathway

    Authors: , , , , , , , , , , - Advanced Science 2022 cited by 76

  12. Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , - Theranostics 2018 cited by 196

  13. Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway

    Authors: , , , , , , , , , - Oncogene 2018 cited by 126

  14. IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell 2007 cited by 632

  15. An LTR Retrotransposon-Derived Long Noncoding RNA lncMER52A Promotes Hepatocellular Carcinoma Progression by Binding p120-Catenin

    Authors: , , , , , , , , , , , , - Cancer Research 2019 cited by 73

  16. Aldolase A Accelerates Cancer Progression by Modulating mRNA Translation and Protein Biosynthesis via Noncanonical Mechanisms

    Authors: , , , , , , , , , - Advanced Science 2023 cited by 32

  17. The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 227

  18. Transcriptome‐Wide Analysis Reveals the Landscape of Aberrant Alternative Splicing Events in Liver Cancer

    Authors: , , , , - Hepatology 2018 cited by 165

  19. Splicing Regulator p54nrb/Non–POU Domain–Containing Octamer‐Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box–Dependent Interacting Protein 1 in Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , - Hepatology 2019 cited by 69

  20. The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation

    Authors: , , , , , , , , , , , , , , , , , , , - Science Advances 2019 cited by 142

  21. Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A/HDAC1/2 complex in non-small cell lung cancer

    Authors: , , , , , , , , , , , , , , , - Cell Death and Disease 2023 cited by 25

  22. RNA binding protein RALY activates the cholesterol synthesis pathway through an MTA1 splicing switch in hepatocellular carcinoma

    Authors: , , , , , , , , , , - Cancer Letters 2022 cited by 38

  23. MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway

    Authors: , , , , , , , , , , , , , , , - Cancer Research 2017 cited by 181

  24. Hypoxia-inducible factor 1 alpha–activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1/integrin β1 signaling in human hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , - Hepatology 2011 cited by 180